.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Achieving high-precision subcellular neural stimulation remains a significant hurdle in the field of bioelectronics. Traditional electrodes often lack the necessary spatial resolution to interact with individual neuronal components. Consequently, clinicians and researchers have sought technologies that combine micrometer-scale footprints with reliable charge-delivery capabilities. A recent study introduces the Subcellular-Scale Stimulation Electrode Arrays (3SEA), which utilizes a novel coating strategy to address these limitations. This advancement offers a scalable framework for developing high-performance neural interfaces and bioelectronic devices.
The core of this breakthrough lies in a diffusion-tuned galvanostatic deposition strategy. This method allows for the uniform application of PEDOT:PSS across densely packed electrode arrays. Specifically, the electrodes feature diameters ranging from only 3 to 10 μm. By mediating mass transport during the coating process, the researchers achieved robust electrochemical performance. These arrays exhibit impedance levels between tens and hundreds of kilohms at 1 kHz. Furthermore, the 3SEA system demonstrates a remarkable charge-storage capacity, ranging from 22.1 to 54.1 mC/cm².
Superior charge-injection capacity is essential for effective subcellular neural stimulation without damaging sensitive biological tissue. The 3SEA electrodes achieve capacities of 2.31 to 10.1 mC/cm², which significantly surpasses previously reported values for microelectrodes. To validate these findings, the research team employed calcium imaging of HT-22 neurons. The results confirmed reliable stimulus-evoked calcium transients. Notably, the system achieved efficient stimulation using biphasic pulses as low as 1 nC/phase. Therefore, this technology provides the precision needed for targeted therapeutic interventions in neurological disorders.
The development of 3SEA represents a major step toward sophisticated neuroprosthetics and brain-computer interfaces. Because the fabrication framework is scalable, it may soon lead to broader clinical applications in deep brain stimulation and epilepsy management. Additionally, the high spatial density of these arrays allows for more naturalistic modulation of neural circuits. As these technologies mature, they will likely become integral to the next generation of precision medicine in neurology.
The 3SEA array is unique due to its subcellular-scale footprint (3-10 μm) and its high charge-injection capacity. This allows for extremely precise stimulation of neural structures with minimal power and reduced risk of tissue damage.
The PEDOT:PSS coating, applied via a diffusion-tuned strategy, lowers the electrochemical impedance and increases the charge-storage capacity of the electrodes. This results in more efficient and reliable charge delivery during neuromodulation.
Potential applications include high-precision deep brain stimulation, advanced neuroprosthetics for sensory restoration, and targeted treatments for neurological conditions like epilepsy and chronic pain.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References
Duan Q et al. Subcellular-Scale Stimulation Electrode Arrays (3SEA) Enabled by Diffusion-Tuned PEDOT:PSS Galvanostatic Deposition. Nano Lett. 2026 Mar 03. doi: 10.1021/acs.nanolett.5c06350. PMID: 41773494.
Cogan SF. Neural Stimulation and Recording Electrodes. Annu Rev Biomed Eng. 2008;10:275-309.
Khodagholy D et al. In vivo recordings of brain activity using organic transistor-based arrays. Nat Commun. 2013;4:1575.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
New 3SEA electrode arrays enable high-precision subcellular neural stimulation with efficient charge delivery, advancing neuroprosthetic development....
5 months ago
A Bayesian network meta-analysis evaluated non-surgical treatments for benign thyroid nodules, finding thermal ablation techniques like laser and radiofrequency ablation superior in nodule volume reduction, whereas levothyroxine showed the strongest TSH suppression without significant changes in FT3 or FT4.
Today
A retrospective study demonstrates that deep learning models using longitudinal digital breast tomosynthesis significantly enhance 5-year breast cancer risk prediction compared to single-timepoint imaging and clinical models.
Today
Researchers developed poly(trimethylene carbonate)-based polymersomes loaded with L-arginine for ROS-triggered nitric oxide release. This mild, stable nano-delivery system produces gas in response to hydrogen peroxide, offering a promising, targeted platform for cardiovascular, surgical, and oncological therapy.
Today
Researchers developed a Haversian-inspired composite scaffold that addresses delayed vascularization and wet-state mechanical deterioration in critical bone defect repair. By integrating spatially programmed calcium phosphate minerals and selective silica reinforcement, the design promotes vascularized bone repair.
Yesterday
A landmark study analyzing over 56,000 adult health records in Delhi-NCR reveals that hypertension and diabetes coexistence affects nearly 5% of adults. The prevalence doubles expected rates and rises sharply after age 40. Early integrated screening is essential to prevent microvascular and macrovascular complications.
Today
